Crossject gender equality score reaches 96/100 in 2024
March 08 2024 - 12:30AM
Dijon, France, March 8, 2024 – 7:30 pm CET -- Crossject
(ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company
developing needle-free auto-injectors for emergency
situations, today announces its EU Gender Equality Index
score reached 96/100 for 2024, marking the third successive year it
has been above 90%.
The Gender Equality Index is a tool to measure the progress of
gender equality in the EU, giving more visibility to areas that
need improvement and ultimately supporting policy makers to design
more effective gender equality measures. It is assessed by a score
from 1 to 100, with 100 meaning full equality between women and
men.
“We are very proud to reach a record score for gender equality,
which is a very important area for Crossject as a maturing public
company, in 2024. This reinforces Crossject’s commitment to being a
responsible and sustainable company, adding to significant
improvements in our Gaïa rating for environment, social and
governance performance,” said Patrick Alexandre, CEO of
Crossject.
About Crossject
Crossject SA (Euronext: ALCJ;
www.crossject.com) is an emerging specialty pharma company. It is
in advanced regulatory development for ZEPIZURE®, an epileptic
rescue therapy, for which it was awarded a $60 million contract
with the U.S. Biomedical Advanced Research and Development
Authority (BARDA). ZEPIZURE® is based on the Company’s
award-winning needle-free autoinjector ZENEO®, designed to enable
patients and untrained caregivers to easily and instantly deliver
emergency medication via intramuscular injection on bare skin or
even through clothing. The Company’s other products in development
include rescue therapies for allergic shocks, adrenal
insufficiencies, opioid overdose and asthma attacks.
For further information, please contact:
Investors Natasha DrapeauCohesion Bureau+41 76 823
75 27natasha.drapeau@cohesionbureau.com |
MediaSophie BaumontCohesion Bureau+33 6 27 74 74
49sophie.baumont@cohesionbureau.com |
|
- 2024-03- 08- Crossject_Press release_Gender Equality_EN
Crossject (EU:ALCJ)
Historical Stock Chart
From Apr 2024 to May 2024
Crossject (EU:ALCJ)
Historical Stock Chart
From May 2023 to May 2024